Department of Surgery, The Ohio State University Wexner Medical Center, Columbus.
Comprehensive Cancer Center, The Ohio State University, Columbus.
Surgery. 2019 Apr;165(4):782-788. doi: 10.1016/j.surg.2018.12.021. Epub 2019 Feb 13.
Advances in communication technology have enabled new methods of delivering test results to cancer survivors. We sought to determine patient preferences regarding the use of newer technology in delivering test results during cancer surveillance.
A single institutional, cross-sectional analysis of the preferences of adult cancer survivors regarding the means (secure digital communication versus phone call or office visit) to receive surveillance test results was undertaken.
Among 257 respondents, the average age was 59.1 years (SD 13.5) and 61.8% were female. Common malignancies included melanoma/sarcoma (29.5%), thyroid (25.7%), breast (22.8%), and gastrointestinal (22.0%) cancer. Although patients expressed a relative preference to receive normal surveillance results via MyChart or secure e-mail, the majority preferred abnormal imaging (87.2%) or blood results (85.9%) to be communicated by in-office appointments or phone calls irrespective of age or cancer type. Patients with a college degree or higher were more likely to prefer electronic means of communication of abnormal blood results compared with a telephone call or in-person visit (odds ratio 2.18, 95% confidence interval: 1.01-4.73, P < .05). In contrast, patients >65 years were more likely to express a preference for telephone or in-person communication of normal imaging results (odds ratio: 2.03, 95% CI: 1.16-3.56, P < .05) versus patients ≤65 years. Preference also varied according to malignancy type.
Although many cancer patients preferred to receive "normal" surveillance results electronically, the majority preferred receiving abnormal results via direct conversation with their provider. Shifting routine communication of normal surveillance results to technology-based applications may improve patient satisfaction and decrease health care system costs.
通信技术的进步使为癌症幸存者提供检测结果的新方法成为可能。我们旨在确定癌症监测期间使用新技术传递检测结果时患者的偏好。
对 257 名成年癌症幸存者对接收监测检测结果的方式（安全数字通信与电话或门诊就诊）的偏好进行了单机构、横断面分析。
在 257 名受访者中，平均年龄为 59.1 岁（标准差 13.5），61.8%为女性。常见的恶性肿瘤包括黑色素瘤/肉瘤（29.5%）、甲状腺（25.7%）、乳腺（22.8%）和胃肠道（22.0%）癌症。尽管患者表示相对倾向于通过 MyChart 或安全电子邮件接收正常的监测结果，但大多数患者希望通过门诊预约或电话通知来报告异常影像学（87.2%）或血液检测结果（85.9%），而与年龄或癌症类型无关。具有大学学历或更高学历的患者比通过电话或亲自就诊更倾向于选择电子方式来传递异常血液检测结果（比值比 2.18，95%置信区间：1.01-4.73，P<.05）。相比之下，年龄>65 岁的患者更倾向于选择通过电话或亲自交流来接收正常影像学结果（比值比：2.03，95%置信区间：1.16-3.56，P<.05），而年龄≤65 岁的患者则不倾向于选择这种方式。偏好也因恶性肿瘤类型而异。
尽管许多癌症患者更喜欢通过电子方式接收“正常”监测结果，但大多数患者更倾向于与他们的医生直接交谈来接收异常结果。将常规的正常监测结果的沟通转移到基于技术的应用程序上可能会提高患者满意度并降低医疗保健系统的成本。
